Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance
Go back to Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.52 -0.08 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.60 | 52 Week High | $21.49 | |||
| Open | $5.61 | 52 Week Low | $15.75 | |||
| Day High | $5.74 | P/E | 6.27 | |||
| Day Low | $5.25 | EPS | $0.88 | |||
| Volume | 994,566 | |||||
